Inventor
LUBOMIR SEBO
Inventor
US
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms23%
C07HSugars21%
C09BOrganic dyes or closely-related compounds for producing dyes, e.g. pigments21%
C07KPeptides11%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
C07DHeterocyclic compounds5%
C12NMicroorganisms or enzymes5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
PatentTitleYear
12,416,046Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing202512,391,834Protected dye-labeled reagents202512,162,903Fluorescent polymerase enzyme substrates having protein shields202412,060,383Protected fluorescent reagent compounds202412,037,641Modified nucleotide reagents202412,000,000Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing202411,884,826Protected dye-labeled reagents202411,781,177Modified biotin-binding proteins for immobilization202311,718,639Fluorescent polymerase enzyme substrates having protein shields202311,578,093Protected fluorescent reagent compounds202311,466,319Labeled nucleotide analogs, reaction mixtures, and methods and systems for sequencing202211,359,235Modified nucleotide reagents202211,203,689Protected dye-labeled reagents2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to PACIFIC BIOSCIENCES CALIFORNIA INC (13)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PACIFIC BIOSCIENCES CALIFORNIA INC | 13 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 13 | 2021–2025 |